January 17th, 2011
Ten years have passed since the first human genome was sequenced and the era of personalized molecular medicine was ushered in with great fanfare. The principal promise was and is simple: the right drug for the right patient at the right dose. Another equally compelling benefit is more efficient drug development. To date, this promise remains largely unrealized. This panel discussion will examine why and how personalized medicine can realize its promise.
December 15th, 2010
On December 15th, a group of America’s leading policy think tanks will host a day-long conference in Washington D.C. to rethink energy innovation. Energy Innovation 2010, held at the National Press Club, will bring together leading experts from government, think tanks, academia, and business to ask hard questions about how energy innovation efforts can be brought to scale, how the innovation system must be restructured and reformed, and how to renew the kind of active partnerships between the public and private sectors that were responsible for so much of America’s prior technological innovation and economic strength.
December 10th, 2010
Chaired by Richard Katz, M.D., of the George Washington University and Jay Wohlgemuth, M.D., of Quest Diagnostics Nichols Institute, the event will be held at George Washington University on January 6, 2011. It is supported and/or co-sponsored by the Personalized Medicine Coalition (PMC), American College of Cardiology (ACC), American Medical Association (AMA), National Heart Lung and Blood Institute (NHLBI), and the Cheney Cardiovascular Institute at George Washington University (GWU). A superb group of speakers, noted in the program agenda below, has been assembled for the conference. At the conference, ACC will release the results of survey research looking at the adoption of personalized medicine and pharmacogenomic concepts and products in cardiovascular practice. The survey will provide new insights into the rate of adoption of personalized medicine among U.S. cardiologists.
November 17th, 2010
Molecular Diagnostics: From Technologies to Treatments
November 17th, 2010
November 4th, 2010
Venture Partner Geoffrey Moore shares lessons in market adoption from other industries at the Consumer Med Summit
November 2nd, 2010
Developing & Acquiring Technology from the Innovation Marketplace
October 28th, 2010
October 21st, 2010
Drug and Biomarker Developments: The Evolution of Blockbusters?
October 19th, 2010
The role of VC in fostering CER & Personalized Medicine